会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • Diagnosis method of endometriosis by detecting biochemical markers and usage of these biochemical markers
    • 通过检测生化标志物和这些生物化学标记物的使用来诊断子宫内膜异位症的方法
    • US20070087386A1
    • 2007-04-19
    • US11250536
    • 2005-10-14
    • Wei-Chung YangChii-Ruey TzengHwei-Jiung Wang
    • Wei-Chung YangChii-Ruey TzengHwei-Jiung Wang
    • G01N33/53
    • G01N33/6893G01N2333/8125G01N2800/364
    • The present invention relates to a non-invasive diagnosis method of endometriosis by detecting biochemical marker in serum or peritoneal fluid, in particular alpha 1-antitrypsin, fragments of alpha 1-antitrypsin, or a combination of both. The diagnosis of endometriosis is performed with observing in serum specimens of a patient the concentration and change of the biochemical marker, in particular molecules related to alpha 1-antitrypsin, and comparing with a predetermined baseline level of the biochemical marker contained in serum. Statistical analysis can be performed to evaluate the baseline level indicating the occurrence of endometriosis. Therefore, the present invention can provide an auxiliary guideline for the diagnosis of endometriosis. The present invention also relates to usage of the biochemical marker.
    • 本发明涉及通过检测血清或腹膜液中的生物化学标记物,特别是α1-抗胰蛋白酶,α1-抗胰蛋白酶的片段或两者的组合来进行子宫内膜异位症的非侵入性诊断方法。 子宫内膜异位症的诊断是在患者的血清标本中观察生化标志物的浓度和变化,特别是与α1-抗胰蛋白酶相关的分子,并与血清中含有的生化标志物的预定基线水平进行比较。 可以进行统计学分析,以评估指示子宫内膜异位症发生的基线水平。 因此,本发明可以为子宫内膜异位症的诊断提供辅助指导。 本发明还涉及生化标志物的用途。
    • 10. 发明授权
    • Diagnosis method of endometriosis by detecting biochemical markers and usage of these biochemical markers
    • 通过检测生化标志物和这些生物化学标记物的使用来诊断子宫内膜异位症的方法
    • US07399598B2
    • 2008-07-15
    • US11250536
    • 2005-10-14
    • Wei-Chung YangChii-Ruey TzengHwei-Jiung Wang
    • Wei-Chung YangChii-Ruey TzengHwei-Jiung Wang
    • G01N33/53
    • G01N33/6893G01N2333/8125G01N2800/364
    • The present invention relates to a non-invasive diagnosis method of endometriosis by detecting biochemical marker in serum or peritoneal fluid, in particular alpha 1-antitrypsin, fragments of alpha 1-antitrypsin, or a combination of both. The diagnosis of endometriosis is performed with observing in serum specimens of a patient the concentration and change of the biochemical marker, in particular molecules related to alpha 1-antitrypsin, and comparing with a predetermined baseline level of the biochemical marker contained in serum. Statistical analysis can be performed to evaluate the baseline level indicating the occurrence of endometriosis. Therefore, the present invention can provide an auxiliary guideline for the diagnosis of endometriosis. The present invention also relates to usage of the biochemical marker.
    • 本发明涉及通过检测血清或腹膜液中的生物化学标记物,特别是α1-抗胰蛋白酶,α1-抗胰蛋白酶的片段或两者的组合来进行子宫内膜异位症的非侵入性诊断方法。 子宫内膜异位症的诊断是在患者的血清标本中观察生化标志物的浓度和变化,特别是与α1-抗胰蛋白酶相关的分子,并与血清中含有的生化标志物的预定基线水平进行比较。 可以进行统计学分析,以评估指示子宫内膜异位症发生的基线水平。 因此,本发明可以为子宫内膜异位症的诊断提供辅助指导。 本发明还涉及生化标志物的用途。